Annovis made significant progress by advancing the buntanetap program, successfully completing two clinical trials-Phase 2/3 ...

Milestone Pharmaceuticals faces a pivotal FDA PDUFA decision for etripamil in PSVT. Read here for a detailed investment ...

The Dnsys X1 is a lower-body "AI-powered" exoskeleton that’s designed to make movement easier on your leg muscles, joints and heart, essentially taking the stress out of walking. It’s designed as both ...

Health officials have reported a sharp rise in cases of Hand, Foot and Mouth Disease (HFMD), confirming 66 infections across ...

A study from Hiroshima University found that when people were told to imagine their virtual bodies in pain, their brains ...

Medtronic’s VenaSeal Spectrum postmarket clinical trial program is highlighting the need for further patient-centric ...

Multibranched thoracoabdominal stent grafts have demonstrated broad applicability, especially for urgent repairs of ...

Liam Lawson charged into view on his first flying lap of the Chinese Grand Prix weekend. For an instant, he looked prodi ...

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

An Assembly committee approved a bill requiring health insurers to increase coverage for ovarian cancer screenings during a ...

Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.